These results suggest that a misfolding-specific intrabody prone to synergistic proteolysis by proteasomal and autophagic pathways is a promising strategy for mitigation of TDP-43 proteinopathy in ALS. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.